Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5435-5441

  De Freitas Cordeiro Silva, Melissa ^a   Lima Oliveira, Zilda Fagundes ^b   De Podestá, José Roberto Vasconcelos ^b   Gouvea, Sonia Alves ^a   Von Zeidler, Sandra Ventorin ^a   Louro, Iúri Drumond ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b HOSPITAL SANTA RITA   (Brazil)

Author keywords

Cancer related genes; Methylation status; Normal oral mucosa; Oral squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER CELL; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 2A GENE; DISEASE MARKER; DNA METHYLATION; DNA SEQUENCE; ENDOTHELIN RECEPTOR B GENE; EPIGENETICS; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; ONCOGENE; POLYMERASE CHAIN REACTION; RUNT RELATED TRANSCRIPT FACTOR 3 GENE; SQUAMOUS CELL CARCINOMA; STRATIFIN GENE; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84855236320     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0698-1     Document Type: Article

References (61)

1. Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J Am Dent Assoc 132:7-11
2. Stewart BW, Kleihues P (2003) World cancer report. International Agency for Research on Cancer, Lyon
3. Tsantoulis PK, Kastrinakis NG, Tourvas AD et al (2007) Advances in the biology of oral cancer. Oral Oncol 43:523-534 (Pubitemid 46860349)
4. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197 (Pubitemid 18061141)
5. Durazzo MD, Araujo CEN, Brandão Neto JS et al (2005) Clinical and epidemiological features of oral cancer in a medical school teaching hospital from 1994 to 2002: increasing incidence in women, predominance of advanced local disease, and low incidence of neck metastases. Clinics 60(4):293-298
6. Califano J, van der Riet P, Westra W et al (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488-2492 (Pubitemid 26170679)
7. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancer-ization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968
8. Spitz MR (1994) Epidemiology and risk factors for head and neck cancer. Semin Oncol 21:281-288 (Pubitemid 24191586)
9. Morse DE, Katz RV, Pendrys DG (1996) Smoking and drinking in relation to oral epithelial dysplasia. Cancer Epidemiol Bio-markers Prev 5:769-777 (Pubitemid 26346275)
10. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-33 (Pubitemid 41828945)
11. Ha PK, Benoit NE, Yochem R et al (2003) A transcriptional progression model for head and neck cancer. Clin Cancer Res 9(8):3058-3064 (Pubitemid 36993268)
12. Kulkarni V, Saranath D (2004) Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol 40:145-153 (Pubitemid 38030357)
13. Maruya S, Issa JP, Weber RS et al (2004) Differential methyla-tion status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10:3825-3830 (Pubitemid 38697618)
14. López M, Aguirre JM, Cuevas N et al (2003) Gene promoter hypermethylation in oral rinses of leukoplakia patients-a diagnostic and/or prognostic tool? Eur J Cancer 39:2306-2309 (Pubitemid 37214854)
15. Rosas SL, Koch W, Carvalho MGC et al (2001) Promoter hypermethylation patterns of p 16, 06- Methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61:939-942
16. Pattani KM, Zhang Z, Demokan S et al (2010) Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) 3(9):1093-1103
17. Christensen BC, Houseman EA, Godleski JJ et al (2009) Epige-netic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 69:227-234
18. Marsit CJ, Christensen BC, Houseman EA et al (2009) Epigenetic profiling reveals etiologically distinct patterns of DNA methyla-tion in head and neck squamous cell carcinoma. Carcinogenesis 30:416-422
19. Herman JG, Graff JR, Myöhänen S et al (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93(18):9821-9826 (Pubitemid 26296693)
20. Jerónimo C, Henrique R, Campos PF et al (2003) Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 56(1):52-55 (Pubitemid 36132475)
21. Kim TY, Lee HJ, Hwang KS et al (2004) Methylation of runx3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84(4):479-484 (Pubitemid 41656475)
22. Ferguson AT, Evron E, Umbricht CB et al (2000) High frequency of hypermethylation at the 14-3-3r locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049-6054 (Pubitemid 30367521)
23. Bender CM, Pao MM, Jones PA (1998) Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58(1):95-101 (Pubitemid 28027723)
24. Pao MM, Tsutsumi M, Liang G et al (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10(9):903-910 (Pubitemid 32401406)
25. Kim WJ, Kim EJ, Jeong P et al (2005) Runx3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65(20):9347-9354 (Pubitemid 41508002)
26. Negraes PD, Favaro FP, Camargo JL et al (2008) DNA methyl-ation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection. BMC Cancer 8:238
27. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163-167 (Pubitemid 29070360)
28. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2:210-219 (Pubitemid 37328790)
29. Ha PK, Califano JA (2006) Promoter methylation and inactiva-tion of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7:77-82 (Pubitemid 43025396)
30. Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31(1):27-36
31. Bornman DM, Mathew S, Alsruhe J et al (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159(3):831-835 (Pubitemid 32847174)
32. Kwabi-Addo B, Chung W, Shen L et al (2007) Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13:3796-3802 (Pubitemid 47037584)
33. Christensen BC, Houseman EA, Marsit CJ et al (2009) Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5:e1000602
34. Feil R (2006) Environmental and nutritional effects on the epi-genetic regulation of genes. Mutat Res 600:46-57
35. Waterland RA (2006) Assessing the effects of high methionine intake on DNA methylation. J Nutr 136:1706S-1710S (Pubitemid 43765384)
36. von Zeidler SV, Miracca EC, Nagai MA et al (2004) Hyperme-thylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med 14(5):807-811
37. Bollati V, Baccarelli A, Hou L et al (2007) Changes in DNA methylation patterns in subjects exposed to lowdose benzene. Cancer Res 67:876-880
38. Miremadi A, Oestergaard MZ, Pharoah PD et al (2007) Cancer genetics of epigenetic genes. Hum Mol Genet 16(Spec No1): R28-R49 (Pubitemid 47241841)
39. Nakajima T, Enomoto S, Ushijima T (2008) DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med 13:8-15
40. Kato K, Hara A, Kuno T et al (2006) Aberrant promoter hyper-methylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 132:735-743 (Pubitemid 44337934)
41. El Naggar AK, Hurr K, Batsakis JG et al (1995) Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 55: 2656-2659
42. Scully C, Field JK, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma: clinico-pathological applications. Oral Oncol 36:404-413 (Pubitemid 30645974)
43. Zochbauer-Muller S, Lam S, Toyooka S et al (2003) Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 107:612-616 (Pubitemid 37296123)
44. Franceschi S, Barzan L, Talamini R (1997) Screening for cancer of the head and neck: if not now, when? Oral Oncol 33(5): 313-316 (Pubitemid 28129231)
45. Bhutani M, Pathak AK, Fan YH et al (2008) Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 1(1):39-44
46. Shaw RJ, Liloglou T, Rogers SN et al (2006) Promoter methyl-ation of P16, RARb, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94:561-568 (Pubitemid 43289761)
47. Hall GL, Shaw RJ, Field EA et al (2008) p16 Promoter methyl-ation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 17(8): 2174-2179
48. Shen L, Kondo Y, Rosner GL et al (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97:1330-1338 (Pubitemid 41487800)
49. Li QL, Ito K, Sakakura C et al (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124 (Pubitemid 34327521)
50. Kim TY, Lee HJ, Hwang KS et al (2004) Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84:479-484 (Pubitemid 41656475)
51. Ku JL, Kang SB, Shin YK et al (2004) Promoter hypermethy-lation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23:6736-6742
52. Ito K, Liu Q, Salto-Tellez M et al (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65:7743-7750 (Pubitemid 41297249)
53. Kim WJ, Kim EJ, Jeong P et al (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65:9347-9354 (Pubitemid 41508002)
54. Mor T, Nomoto S, Koshikawa K et al (2005) Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 25:380-388
55. Yanada M, Yaoi T, Shimada J et al (2005) Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol Rep 14:817-822
56. Gao F, Huang C, Lin M et al (2009) Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocaliza-tion in oral squamous cell carcinomas. J Cancer Res Clin Oncol 135(5):739-747
57. Wolff EM, Liang G, Cortez CC et al (2008) RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res 68(15):6208-6214
58. Nelson JB, Lee WH, Nguyen SH et al (1997) Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 57:35-37 (Pubitemid 27020325)
59. Gasco M, Bell AK, Heath V et al (2002) Epigenetic inactivation of 14-3-3 d in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res 62(7):2072-2076 (Pubitemid 34408454)
60. Bhawal UK, Tsukinoki K, Sasahira T et al (2007) Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Oncol Rep 18(4):817-824
61. Bhatia K, Siraj AK, Hussain A et al (2003) The tumor suppressor gene 14-3-3r is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev 12:165-169 (Pubitemid 36194008)